1 / 6

Follicular Lymphoma Pipeline Assessment Review H1 2015

This report gives broad information on the medicinal change for Follicular Lymphoma, complete with relative examination at diverse stages, therapeutics evaluation by pharmaceutical target, segment of movement (MoA), course of association (RoA) and molecule sort, close by latest overhauls, and highlighted news and press releases. It in like manner studies key players included in the healing change for Follicular Lymphoma and remarkable segments on late-organize and finished endeavors.

jack2222simon
Download Presentation

Follicular Lymphoma Pipeline Assessment Review H1 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Follicular Lymphoma - Pipeline Review, H1 2015 By RnRMarketResearch.com Publisher Name : Global Market Direct Date: 24-Jun-2015 No. of pages: 438 Single User License: US $2000 Browse more Reports on Cancer Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/cancer-therapeutics . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Follicular Lymphoma - Pipeline Review, H1 2015 This report gives broad information on the medicinal change for Follicular Lymphoma, complete with relative examination at diverse stages, therapeutics evaluation by pharmaceutical target, segment of movement (MoA), course of association (RoA) and molecule sort, close by latest overhauls, and highlighted news and press releases. It in like manner studies key players included in the healing change for Follicular Lymphoma and remarkable segments on late-organize and finished endeavors. The report enhances decision making capacities and help to make convincing counter systems to build distinct advantage. It fortifies R&D pipelines by perceiving new targets and MOAs to make first-in-class and best-in-class things. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Follicular Lymphoma - Pipeline Review, H1 2015 Companies Discussed/Mentioned in this Research: AbbVie Inc., Accentia Biopharmaceuticals, Inc., Affimed Therapeutics AG, AmpliMed Corporation, Bayer AG, Bio-Path Holdings, Inc., Biocon Limited, Biogenomics Limited, Biothera, Inc., BoehringerIngelheim GmbH, Bristol-Myers Squibb Company, Celgene Corporation, Celltrion, Inc., Cellular Biomedicine Group, Inc., CTI BioPharma Corp., CureTech Ltd., Curis, Inc., Dynavax Technologies Corporation, Eisai Co., Ltd., Emergent BioSolutions Inc., EpiZyme, Inc., F. Hoffmann-La Roche Ltd. And more Drugs Profile Discussed in this Research : abexinostat hydrochloride, ACP-196, AFM-11, alisertib, ASN-002, atezolizumab, azacitidine, Betalutin, bortezomib, BP-100102, buparlisib hydrochloride, BVX-20, CBM-C19.1, CBM-C20.1, Cell Therapy to Target CD22 for B-Cell Leukemia and Lymphoma, Cell Therapy to Target GM-CSF for Oncology, cerdulatinib, copanlisib hydrochloride, CUDC-907, daratumumab, dasiprotimut-T, denintuzumabmafodotin and more ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Follicular Lymphoma - Pipeline Review, H1 2015 Scope For Follicular Lymphoma - Pipeline Review, H1 2015 • The report provides a snapshot of the global therapeutic landscape of Follicular Lymphoma • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Follicular Lymphoma and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A review of the Follicular Lymphoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Follicular Lymphoma - Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Follicular Lymphoma • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Follicular Lymphoma pipeline depth and focus of Indication therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Follicular Lymphoma - Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related